CD44 and neoplasm: Tumorigenic PC3 cells may be enriched by the ALDH+ phenotype but not ABCG2 whereas only the CD44+α2β1+ phenotype can enrich tumor-initiating cells in the LAPC4 model (Supplementary Table 4).